Dendritic cell-mediated antigen-presenting pathways

Dendritic cell-mediated antigen-presenting pathways are fundamental biological processes that bridge innate and adaptive immunity (Banchereau & Steinman, 1998). Dendritic cells (DCs) act as professional antigen-presenting cells by capturing, processing, and presenting antigens on Major Histocompatibility Complex (MHC) molecules to T cells (Mellman & Steinman, 2001). This presentation, combined with costimulatory signals such as CD80 and CD86 and the secretion of polarizing cytokines like IL-12, is essential for the activation and differentiation of naive T cells into effector cells (StatPearls, 2023). These pathways play a pivotal role in orchestrating immune responses against pathogens and tumors while maintaining self-tolerance to prevent autoimmunity (Roche & Furuta, 2015). In oncology, these pathways are targeted by DC-based vaccines like Sipuleucel-T and toll-like receptor (TLR) agonists such as Imiquimod to enhance anti-tumor immunity (FDA, 2010; StatPearls, 2023). Conversely, in transplantation and autoimmune diseases, these pathways are inhibited by drugs like Abatacept, which blocks costimulatory signals, to suppress unwanted immune activation (Bluestone et al., 2006). Understanding the molecular components of these pathways is crucial for developing targeted immunotherapies across various disease states.

Other names

Antigen presentation by dendritic cellsDC-mediated antigen processingDendritic cell activation pathwayCross-presentation pathwayMHC-mediated antigen presentation in dendritic cells

Modulation of dendritic cell maturation, antigen loading, or costimulatory signal transduction to enhance or suppress T-cell mediated immune responses (StatPearls, 2023; Bluestone et al., 2006).